|
Karnataka to invest Rs. 600-cr for deeptech; expected to fund AI-pharma as life sciences takes centre-stage
|
|
Nandita Vijayasimha, Bengaluru
November 22 , 2025
|
|
|
In a bold move to strengthen its position as a hub for cutting-edge technology, the Karnataka government has committed a whopping Rs. 600 crore towards advancing deeptech innovations. A primary focus of this funding will be the AI-pharma sector, which is set to revolutionize the pharmaceutical industry through breakthroughs in drug discovery, personalized medicine, and healthcare solutions powered by artificial intelligence.
As life sciences takes centre-stage at the just concluded three-day Bangalore Tech Summit (BTS) 2025 held from November 18 to 20, this investment underscores the state's commitment to nurturing a robust ecosystem which combines technological advancements with lifesciences, positioning Karnataka as a key player in the global deeptech landscape.
At the Digi Health & Biotech Track, among the key thematic tracks in BTS?2025 focused on AI driven diagnostics, health data, sustainable bio-manufacturing, R&D and drug discovery. Indian pharma is witnessing a transformative surge as artificial intelligence (AI) reshapes every stage of drug development, manufacturing, and distribution. With advanced algorithms enabling faster data analysis, predictive modelling, and automation, AI is significantly reducing research timelines, improving accuracy, and enhancing decision-making across the sector.
On the sidelines of the recently concluded Bangalore Tech Summit (BTS) 2025, experts from pharma and biotech said that AI applications are accelerating drug discovery to optimizing supply chains and strengthening regulatory compliance, these innovations are giving the pharma industry a powerful push toward greater efficiency, precision, and global competitiveness.
The 3-day BTS showcased the transformative role of AI in propelling the pharmaceutical sector. Abhijeet Singh, additional secretary, MeitY, highlighted India’s AI ambitions in his keynote address ‘Building a Shared Future: Indo-US Partnership for AI’ and panel session ‘AI Universe Opening Session: The Road to India AI Impact Summit.’
Highlighting the country’s vast pool of engineers, researchers, and innovators, he noted that India is now powering breakthroughs across healthcare, agriculture, fintech, mobility, and public services—emerging as a global force in the AI revolution.
Also, the Indian pharmaceutical industry is increasingly turning to AI powered regulatory intelligence tools to stay ahead of evolving regulations. This transformation allows regulatory teams to shift from reactive responses to proactive compliance, enhancing speed, accuracy, and scalability.
There is need for upskilling even as India has the brain power and the cognitive skills. A typical example of AI is that it is being used to create new content, such as synthetic data for drug development, and to perform tasks like summarizing patient data, drafting clinical notes, and personalizing treatment plans. Gen AI Gen AI has the potential to reduce clinician burnout, freeing more time for direct patient care. Furthermore, application of Gen AI may enhance surgical outcomes by providing real-time feedback and automation of certain tasks in operating rooms, said experts.
|
|
|
|
|
|
|
|
TOPICS
|
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...
|
|
|
|
|